While reporting financial results for the first quarter on Tuesday, Teva Pharmaceutical Industries Ltd (TEVA) trimmed its revenue guidance for the full-year 2022 to reflect ongoing impact of foreign exchange fluctuations.
from RTT - Earnings https://ift.tt/4IEnlYU
via IFTTT
No comments:
Post a Comment